In today’s recent session, 182.88 million shares of the Pasithea Therapeutics Corp (NASDAQ:KTTA) have been traded, and its beta is 0.53. Most recently the company’s share price was $2.95, and it changed around $1.53 or 108.10% from the last close, which brings the market valuation of the company to $8.74M. KTTA at last check was trading at a discount to its 52-week high of $7.69, offering almost -160.68% off that amount. The share price’s 52-week low was $0.92, which indicates that the recent value has risen by an impressive 68.81% since then.
Pasithea Therapeutics Corp stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended KTTA as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Pasithea Therapeutics Corp (NASDAQ:KTTA) trade information
Instantly KTTA has been showing a green trend so far today with a performance of 108.10% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.7900 on recent trading dayincreased the stock’s daily price by 22.16%. The company’s shares are currently down -6.19% year-to-date, but still up 80.18% over the last five days. On the other hand, Pasithea Therapeutics Corp (NASDAQ:KTTA) is 132.68% up in the 30-day period.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -282.28%.
KTTA Dividends
Pasithea Therapeutics Corp’s next quarterly earnings report is expected to be released in June.
AdvisorShares Trust-AdvisorShares Psychedelics ETF and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 53.55 shares worth $92100.0, making up 1.81% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held roughly 2.96 shares worth around $5098.0, which represents about 0.10% of the total shares outstanding.
